Skip to main content

Table 3 Primary and secondary patency of the VA stratified by the sides and locations of VA

From: Impact of transvenous cardiac implantable electronic devices in chronic hemodialysis patients: a single-center, observational comparative study

  

Ipsilateral vs contralateral VA

Forearm vs upper arm VA

Total

Ipsilateral VA

Contralateral VA

P value

Forearm

Upper arm

P value

(n = 42)

(n = 22)

(n = 20)

(n = 33)

(n = 9)

CIED after VA

16 (38.1)

5 (22.7)

11 (55)

0.03

13 (39.4)

3 (33.3)

0.74

 Time interval (months)

25 (1–117)

7 (1–40)

29 (4–117)

0.14

22 (1–117)

29 (8–61)

0.32

Primary patency (months)

59 (1–136)

34 (1–117)

65 (1–136)

0.70

59 (1–136)

49 (1–49)

0.76

 1 year (%)

71

67

74

0.72

66

89

0.29

 3 years (%)

57

45

68

0.39

53

67

0.39

 5 years (%)

46

34

56

0.36

NA

NA

NA

Secondary patency (months)

65 (1–136)

59 (1–117)

78 (1–136)

0.60

59 (1–136)

45 (1–51)

0.31

 1 year (%)

82

81

84

0.81

80

89

0.61

 3 years (%)

67

50

84

0.12

62

89

0.31

 5 years (%)

52

38

67

0.15

NA

NA

NA

  1. Continuous data are expressed as medians (ranges)
  2. CIED cardiac implantable electronic device, NA not applicable, VA vascular access